Study Coming Soon – Phase I Clinical Research Study – HYR-PB21
Frontage Clinical Services prioritizes the safety and well-being of our study participants, our employees, and visitors to our clinic. As such, we have incorporated additional policies and procedures, as recommended by the CDC.
Participate in a Phase I Clinical Trial
Frontage Clinical Services is seeking healthy adult volunteers to participate in a Phase I clinical research study evaluating HYR-PB21, an investigational long-acting local anesthetic. The study will assess the safety, tolerability, and pharmacokinetics (how the body processes the drug) of HYR-PB21 compared to standard Bupivacaine HCl Injection.
To participate, you must:
- Be a Healthy Adult
- Be 18 to 55 years old
- Have a BMI between 18.0 and 32.0 kg/m² (Must be at least 110lbs)
- Have a Good Venous Access
Study Requirements:
- 7 overnight (6 days) stays at the research unit followed by 1 outpatient visit.
- A double abdominal injection of investigational study medication
- Compensation up to $3,850 for your time and participation.